Publication | Open Access
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration
45
Citations
20
References
1996
Year
Intravenous AdministrationNew TopoisomeraseMedicinePharmacotherapyAnti-cancer AgentDaily X 5PharmacologyDrug DiscoveryTranslational Pharmacology
| Year | Citations | |
|---|---|---|
Page 1
Page 1